Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ruijin Hospital | OTHER |
| Zhejiang Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.
Adult ICU patients were prospectively and consecutively enrolled across 11 research centers. MDRGNB infection risk predictions were generated within 24 hours of ICU admission using routinely available clinical data. Without interfering with clinical decision-making, the study assessed the discrimination, calibration, and clinical net benefit of the previously developed MDRGNB infection risk prediction model in real-world practice, applying the predefined threshold of 0.318.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observation group |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| MDRGNB infection | The objective of this study was to observe whether enrolled patients developed early MDRGNB infection and to validate the model's performance. The occurrence of MDRGNB infection was adjudicated by integrating clinical manifestations with culture results from collected specimens.Baseline and model variables: Collected within 48 hours of ICU admission.Primary outcome: Determined based on the results of the first submitted specimen. | 48 hours after ICU admission |
| Measure | Description | Time Frame |
|---|---|---|
| 28-day mortality | 28-day mortality | 28 day after ICU admission |
| Sequential Organ Failure Assessment (SOFA) score at 48 hours | SOFA score at 48 hours, higher SOFA score mean a worse outcome |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult ICU patients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dayu Chen, Pharmacist in Charge, PharmD | Contact | +86-025-83106666-60924 | cdy_pharmacy@njglyy.com | |
| Juan He, Professor, PharmD | Contact | hejuanwin@126.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nanjing Drum Tower Hospital | Recruiting | Nanjing | Jiangsu | 210008 | China |
De-identified original data.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 48 hours after ICU admission |
| Adverse events related to antibiotic within 28 days | Adverse events related to antibiotic within 28 days, defined by Naranjo scale. | 28 day after admission |
| Ankang People's Hospital | Not yet recruiting | Ankang | China |
|
| Sinopharm Tongmei General Hospital | Not yet recruiting | Datong | China |
|
| First Affiliated Hospital of Gannan Medical University | Not yet recruiting | Ganzhou | China |
|
| Zhejiang Hospital | Recruiting | Hangzhou | China |
|
| Zhejiang Provincial People's Hospital | Not yet recruiting | Hangzhou | China |
|
| Huaian First People's Hospital | Not yet recruiting | Huaian | China |
|
| Guangxi Provincial Tumor Hospital | Recruiting | Nanning | China |
|
| Shanghai Ruijin Hospital | Recruiting | Shanghai | China |
|
| Shaanxi Provincial People's Hospital | Not yet recruiting | Xi'an | China |
|
| Zhanjiang Central People's Hospital | Not yet recruiting | Zhanjiang | China |
|